QID 150719

Date Published: 2023-09-25

QID 150719: PaperCut NG/MF Path Traversal Vulnerability (CVE-2023-39143)

PaperCut NG/MF is a comprehensive print management system designed to seamlessly monitor and control your resources with easy to use administrative and user tools that can be securely accessed from anywhere on the network though a web browser.

Multiple versions of PaperCut NG/MF running on Windows are affected by Path Traversal vulnerability which could further lead to Remote Code Execution (RCE).

Affected Products:
PaperCut NG/MF prior to version 22.1.3

QID Detection Logic (Unauthenticated):
This QID sends HTTP GET request and tries to fetch "home-app.png" using specially crafted Path Traversal payload and based on the response determines if the host is vulnerable

Successful exploitation of this vulnerability could allow an unauthenticated attacker to access upload, read, or delete arbitrary files and leads to Remote Code Execution (RCE) when external device integration configuration is enabled.

  • CVSS V3 rated as Critical - 9.8 severity.
  • CVSS V2 rated as Critical - 10 severity.
    • Solution
    Customers are advised to upgrade to latest version of PaperCut NG/MF to remediate this vulnerability. For more information regarding patch details please refer PaperCut Security Bulletin.
    Vendor References

    CVEs related to QID 150719

    CVE-2023-39143 |
    Software Advisories
    Advisory ID Software Component Link
    PaperCut Security Bulletin URL Logo www.papercut.com/kb/Main/securitybulletinjuly2023/
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].